Tenet Healthcare (THC) closed at $173.66, up 1.32% from the previous day, outperforming the S&P 500, Dow, and Nasdaq. Shares rose by 6.19% in the past month, surpassing the Medical sector and S&P 500. Earnings report scheduled for July 22, 2025, projects an EPS of $2.84 and revenue of $5.15 billion.

Analysts predict Tenet Healthcare’s full-year earnings at $12.73 per share and revenue of $20.9 billion, reflecting positive changes from last year. The Zacks Rank system suggests a Hold rating for THC, with a Forward P/E ratio of 13.47. The Medical – Hospital industry has an average PEG ratio of 1.28 and Zacks Industry Rank of 183.

Investors should consider the potential of Tenet Healthcare as a stock to watch. With upcoming earnings and positive analyst estimates, the company shows promise for growth. The Zacks Rank system, with a track record of outperformance, suggests potential for a strong buy signal in the near term. Stay informed with Zacks.com for updates on Tenet Healthcare.

Looking for growth opportunities in the stock market? Discover 7 top stocks with breakout potential before they surge. With only 220 Zacks Rank #1 Strong Buys at a time and a history of outperforming the S&P 500, these stocks offer a chance for significant gains. Download the free report now for insights on the 7 Best Stocks for the Next 30 Days.

Read more at Nasdaq: Tenet Healthcare (THC) Outpaces Stock Market Gains: What You Should Know